Cited by 52Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel‐releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients

Morelli, Michele, Sacchinelli, Angela, Venturella, Roberta, Mocciaro, Rita, Zullo, Fulvio·2013·Journal of Obstetrics and Gynaecology Research

Abstract

Aim: In recent years, both dienogest, a fourth‐generation progestin, and levonorgestrel‐releasing intrauterine device have been found to be effective in terms of endometriosis‐related pelvic pain improvement. No data, however, are available about their efficacy in terms of postoperative recurrence prevention in women recently submitted to surgery for endometriosis at every stage. Our objective was to compare two postoperative medical approaches for pain control and reduction of recurrences in patients undergoing surgery for endometriosis. Material and Methods: Ninety‐two patients undergoing surgery for endometriosis and subsequent treatment by estradiol valerate + dienogest (EP) (group A) or levonorgestrel‐releasing uterine device (LNG‐IUD) (Group B) between J anuary 2009 and J une 2010 were retrospectively analyzed. The primary endpoints were pain relapse and disease recurrence rate at 12 and 24 months. The secondary endpoint was patient satisfaction with the therapy at 24 months. Results: Forty‐eight patients in Group A and 44 in Group B were examined. At 12 and 24 months a statistically greater reduction both in Ca125 levels and VAS score was seen in women treated with EP compared to LNG‐IUD. The recurrence rate at 12 and 24 months follow‐up was slightly lower, but not at a significant level, in Group A than in Group B. Finally, satisfaction with treatment at 24 months was significantly higher in Group B. Conclusion: EP administration is significantly more effective than LNG‐IUD in reducing pelvic pain and more effective in reducing recurrence rate but not at a significant level. LNG‐IUD, however, has significantly higher patient satisfaction.

Integrity signals

Registry

Crossref · 10.1111/jog.12030

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two retrospective studies found that postoperative LNG-IUS use seems comparable to COC in preventing endometrioma recurrence.

    “Two retrospective studies [88,89] compared the efficacy of postoperative use LNG-IUS with COC for preventing endometrioma recurrence. In both cases, postoperative LNG-IUS use seems comparable to that of COC in preventing endometrioma recurrence.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Morelli, M., Sacchinelli, A., Venturella, R., Mocciaro, R., & Zullo, F.
Affiliations
Magna Graecia University (IT)
Corresponding author
Venturella, Roberta
Venue
Journal of Obstetrics and Gynaecology Research
Publisher
Wiley
Published
2013-04-03
Volume
39
Issue
5
Pages
985-990
ISSN
  • 1341-8076 (ISSN-L)
  • 1447-0756
OpenAlex
W1710395003
Cited by
52
References
25
Citations by year
2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 1 · 2018: 9 · 2017: 9 · 2016: 5 · 2015: 2 · 2014: 3 · 2013: 2
FWCI
4.83
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of obstetrics and gynaecology research (publishedVersion)
  • PubMed (publishedVersion)
  • Archive of Doctoral Theses and Digital Collections (University of Calabria) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, dienogest, estradiol valerate, levonorgestrel-releasing intrauterine system, postoperative recurrence prevention, pelvic pain, endometriosis surgery, CA125, patient satisfaction, progestin therapy
MeSH terms
Adult, Combined Modality Therapy, Contraceptive Agents, Female, Drug Combinations, Endometriosis, Estradiol, Estrogens, Female, Follow-Up Studies, Humans, Intrauterine Devices, Medicated, Nandrolone, Postoperative Care, Receptors, Progesterone, Retrospective Studies, Levonorgestrel, Patient Satisfaction, Pelvic Pain, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review